SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-002378
Filing Date
2021-10-27
Accepted
2021-10-27 16:32:34
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20210930.htm   iXBRL 10-Q 2965197
2 EX-31.1 inva-ex31_1.htm EX-31.1 15044
3 EX-31.2 inva-ex31_2.htm EX-31.2 15047
4 EX-32 inva-ex32.htm EX-32 24449
  Complete submission text file 0000950170-21-002378.txt   10159173

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20210930_pre.xml EX-101.PRE 334399
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20210930.xsd EX-101.SCH 44646
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inva-20210930_lab.xml EX-101.LAB 384766
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20210930_cal.xml EX-101.CAL 58275
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20210930_def.xml EX-101.DEF 220865
10 EXTRACTED XBRL INSTANCE DOCUMENT inva-20210930_htm.xml XML 2251256
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 211353430
SIC: 2834 Pharmaceutical Preparations